Aquestive Therapeutics, Inc. ($AQST)
Filing Information
| Accession Number | 0001214659-26-011596 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
26,250
Total Value
$68,862.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Sep 9, 2026 | Exercise/Conversion | 8,750 | $2.65 | $23,187.50 | 244,439 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Sep 9, 2026 | Sale | 8,750 | $5.22 | $45,675.00 | 235,689 | Direct | โ | View Details | |
Chief Commercial Officer | Non-Qualified Stock Option (right to buy) | Derivative | Sep 9, 2026 | Exercise/Conversion | 8,750 | $0.00 | $0.00 | 26,250 | Direct | โ | View Details |